Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design

The value of guided therapy (GT) with anti-P2Y12 drugs in percutaneous coronary intervention (PCI) is unclear. Meta-analyses lumped together randomized controlled trials (RCTs) with heterogeneous designs, comparing either genotype-GT or platelet function test (PFT)-GT with unguided therapy. Some met...

Celý popis

Podrobná bibliografie

Vydáno v:	Thrombosis and haemostasis Ročník 124; číslo 5; s. 482
Hlavní autoři:	Birocchi, Simone, Rocchetti, Matteo, Minardi, Alessandro, Podda, Gian Marco, Squizzato, Alessandro, Cattaneo, Marco
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Germany 01.05.2024
Témata:	Blood Platelets - drug effects Coronary Artery Disease - therapy Genotype Hemorrhage - chemically induced Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - therapeutic use Randomized Controlled Trials as Topic Receptors, Purinergic P2Y12 Treatment Outcome
ISSN:	2567-689X, 2567-689X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!